3,4-Dehydro Cilostazol

• CAT Number: R006499
• CAS Number: 73963-62-9
• Molecular Formula: C20H25N5O2
• Molecular Weight: 367.44
• Purity: ≥95%
• Synonyms: 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1H-quinolin-2-one
• InChI: InChI=1S/C20H25N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h9-12,14,16H,1-8,13H2,(H,21,26)
• InChIKey: GHALECSGOJQOHW-UHFFFAOYSA-N
• SMILES: C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)C=C4

3,4-Dehydro Cilostazol（Cat No.:R006499）is a synthetic derivative of cilostazol, a quinolinone-based phosphodiesterase 3 (PDE3) inhibitor known for its vasodilatory and antiplatelet effects. The 3,4-dehydro modification alters the aromatic ring system, providing a useful structural analog for pharmacological and medicinal chemistry studies. This compound is often employed to investigate structure–activity relationships, optimize drug candidates, and explore mechanisms of cardiovascular regulation. Its design supports applications in research on platelet aggregation, vascular smooth muscle relaxation, and potential therapeutic strategies for cardiovascular and metabolic disorders.